Skip to content

Outcomes After Epigastric Hernia Repair in Women.

Long-term Outcomes After Epigastric Hernia Repair in Women - a Nationwide Database Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06074146
Acronym
EPI-WOMEN
Enrollment
3031
Registered
2023-10-10
Start date
2007-01-01
Completion date
2022-01-01
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epigastric Hernia

Brief summary

Nationwide cohort study on women undergoing epigastric hernia repair

Detailed description

Women have the highest prevalence of epigastric hernia repair. Outcomes after epigastric hernia repair are rarely reported independently, although pathology and surgical techniques may be different than for other primary ventral hernias. The aim of this study was to evaluate long-term outcomes after epigastric hernia repairs in women on a nationwide basis. Methods Nationwide cohort study from the Danish Hernia Database. Complete data from women undergoing elective epigastric hernia repair during a 12-year period (2007-2018) was extracted. A 100% follow-up was obtained by combining data from the National Civil Register. The primary outcome was operation for recurrence, secondary outcomes were readmission and operation for complications. Outcomes for open sutured repair, open mesh repair mesh, and laparoscopic repairs were compared.

Interventions

None listed

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* females undergoing epigastric hernia repair in Denmark

Exclusion criteria

* emergency repair umbilical hernias incisional hernias males

Design outcomes

Primary

MeasureTime frameDescription
hernia recurrenceend of studyreoperation for recurrence

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026